ResearchMoz.us include new market research report" PharmaPoint: Meningococcal Vaccines - UK Drug Forecast and Market Analysis to 2022 " to its huge collection of research reports.

Albany, NY -- (SBWire) -- 10/30/2013 --ResearchMoz.us include new market research report" PharmaPoint: Meningococcal Vaccines - UK Drug Forecast and Market Analysis to 2022 " to its huge collection of research reports.

GlobalData has released its new Country report, “PharmaPoint: Meningococcal Vaccines UK Drug Forecast and Market Analysis to 2022”. Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. For these reasons the meningococcal disease space is dominated by vaccines.

Currently, tetravalent conjugate vaccines, such as Sanofi’s Menactra and Novartis’ Menveo, account for the vast majority of global sales, with the US adolescent market being the key target segment. GlobalData expects growth in the meningococcal vaccines market to be primarily driven by the launch of serotype B vaccines, which address a critical unmet need in the treatment landscape. Vaccines that better protect infants and/or provide a longer duration of immunity also have an opportunity to seize market share during 2012-2022.

View Full This Report With TOC @ http://www.researchmoz.us/pharmapoint-meningococcal-vaccines-uk-drug-forecast-and-market-analysis-to-2022-report.html

GlobalData predicts that relative patient share for the three MenC conjugate vaccines will shift due to changes being made to the UK MenC schedule (DOH, 2013b). Meningitec will lose sales due to its elimination from the single primary dose, with patient share expected to be made up by Menjugate and NeisVac-C.

Scope:

Overview of Meningococcal Vaccines including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
Detailed information on the key drugs in the UK including product description, safety and efficacy profiles as well as a SWOT analysis.
Sales forecast for the top drugs in the UK from 2012-2022.
Analysis of the impact of key events as well the drivers and restraints affecting the UK Meningococcal Vaccines market.

Reasons to buy:

Understand and capitalize by identifying products that are most likely to ensure a robust return
Stay ahead of the competition by understanding the changing competitive landscape for Meningococcal Vaccines
Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
Make more informed business decisions from insightful and in-depth analysis of drug performance
Obtain sales forecast for drugs from 2012-2022 in the UK

Related Reports:

Global Heparin Market 2011-2015 ( http://www.researchmoz.us/global-heparin-market-2011-2015-report.html )

Computed Radiography and Digital Radiography Market in Europe 2011-2015 ( http://www.researchmoz.us/computed-radiography-and-digital-radiography-market-in-europe-2011-2015-report.html )

Browse All Latest Report Related to Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

About ResearchMoz
ResearchMoz ( http://www.researchmoz.us/ ) is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.

For More Information Kindly Contact:

Mrs.Sheela AK
Tel:+1-518-618-1030
Toll Free: 866-997-4948
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Email :sales@researchmoz.us
Website:http://www.researchmoz.us/
Blog :http://researchmoz.blogspot.com